June 22, 2026 a 04:38 pm
BG: Analysts Ratings - Bunge Global S.A.
Bunge Global S.A., a long-standing leader in the international agribusiness sector, has shown consistent performance across its diverse segments. Recent analyst ratings reflect a steady optimism with a predominant inclination towards 'Buy'. An in-depth look at the data reveals subtle shifts indicating a potential rise in confidence among analysts.
Historical Stock Grades
| Rating Category | Number of Ratings | Score |
|---|---|---|
| Strong Buy | 3 | |
| Buy | 5 | |
| Hold | 1 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
Over the past months, the sentiment surrounding Bunge Global S.A. has exhibited stability, with consistently positive ratings. The dominance of "Buy" and "Strong Buy" ratings highlights sustained market confidence. There is no significant increase in "Sell" or "Strong Sell", suggesting a lack of perceived risk among analysts.
- The number of total ratings remained consistent, reflecting steady analyst interest.
- Noticeable increase in "Buy" recommendations aligns with confidence in future performance.
- "Hold" ratings saw a decrease, pointing towards a shift from neutrality to optimism.
Percentage Trends
The analysis of percentage trends over recent periods demonstrates a slight but noteworthy shift towards more aggressive recommendations. The proportion of "Strong Buy" ratings increased, which is indicative of growing analyst confidence in Bunge's strategic direction and market performance.
- Overall, "Strong Buy" ratings increased from 10% to 30%, showcasing heightened optimism.
- "Hold" ratings became less frequent, decreasing from 30% to 10% over the last year.
- The steady percentage of "Buy" ratings suggests sustained confidence.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-04-30 | Overweight | Overweight | Barclays |
| 2026-04-01 | Overweight | Overweight | Barclays |
| 2026-03-24 | Overweight | Overweight | JP Morgan |
| 2026-03-11 | Outperform | Outperform | BMO Capital |
| 2026-03-11 | Overweight | Overweight | Morgan Stanley |
Analyst Recommendations with Change of Opinion
Noteworthy in the analysis are the recommendation updates reflecting altered confidence levels in Bunge's future performance. Upgrades outnumber downgrades, suggesting a stronger market position.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-12-16 | Overweight | Equal Weight | Morgan Stanley |
| 2025-11-06 | Overweight | Equal Weight | Barclays |
| 2025-01-21 | Equal Weight | Overweight | Barclays |
| 2024-08-01 | Neutral | Buy | Citigroup |
| 2024-02-09 | Buy | Hold | HSBC |
Interpretation
The market sentiment towards Bunge Global S.A. appears predominantly positive, with analyst recommendations leaning towards "Buy" and "Strong Buy". This suggests a robust confidence in the company’s strategic trajectory and day-to-day operations. The limited presence of "Hold" and near absence of "Sell" ratings indicate a perceived low risk environment and potential for growth. The consistency in recommendations suggests a stable analyst opinion, which is crucial for potential investors.
Conclusion
Bunge Global S.A. displays a promising outlook within the agribusiness sector, reflected by steady and assertive analyst ratings. The company's operational diversity and global reach support a positive growth narrative. While current market conditions seem favorable, investors should remain aware of potential macroeconomic impacts on the agricultural industry. Nevertheless, the company's capacity for adaptation and innovation provides a solid foundation for future performance. The analyst consensus underlines the potential for sustained growth and profitability, making Bunge an attractive proposition for investors seeking stability with potential upside.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years